Cargando…
Unlocking the potential of established products: toward new incentives rewarding innovation in Europe
Background: Many established products (EPs – marketed for eight years or more) are widely used off-label despite little evidence on benefit–risk ratio. This exposes patients to risks related to safety and lack of efficacy, and healthcare providers to liability. Introducing new indications for EPs ma...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Routledge
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508393/ https://www.ncbi.nlm.nih.gov/pubmed/28740616 http://dx.doi.org/10.1080/20016689.2017.1298190 |